Market Value108,631,000
Total Holdings66
File Date2017-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AGIO / Agios Pharmaceuticals, Inc.
BMY / Bristol-Myers Squibb Company Call
BMY / Bristol-Myers Squibb Company
PGEN / Precigen, Inc.
MRK / Merck & Co., Inc.
ALDR / Alder BioPharmaceuticals, Inc.
IOVA / Iovance Biotherapeutics, Inc.
CLVS / Clovis Oncology Inc
LLY / Eli Lilly and Company Call
PRTK / Paratek Pharmaceuticals Inc.
SIOX / Sio Gene Therapies Inc.
PCRX / Pacira BioSciences, Inc.
TSRO / TESARO, Inc.
CFRX / ContraFect Corp
LOXO / Loxo Oncology, Inc.
BIVV / Bioverativ Inc.
BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology Put
PGNX / Progenics Pharmaceuticals, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
MDCO / Medicines Company
JUNO / Juno Therapeutics, Inc.
STML / Stemline Therapeutics, Inc.
SNR / New Senior Investment Group Inc
MYGN / Myriad Genetics, Inc.
MCRB / Seres Therapeutics, Inc.
KITE / Kite Pharma, Inc.
AVXS / AveXis, Inc.
BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology
US0153511094 / Alexion Pharmaceuticals, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc. Call
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
451731103 / Ignyta, Inc.
0PP / Portola Pharmaceuticals Inc
KPTI / Karyopharm Therapeutics Inc.
ACAD / ACADIA Pharmaceuticals Inc.
PFE / Pfizer Inc.
HRTX / Heron Therapeutics, Inc.
SCYX / SCYNEXIS, Inc.
ADMS / Adamas Pharmaceuticals Inc
AKBA / Akebia Therapeutics, Inc.
AMGN / Amgen Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
GILD / Gilead Sciences, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
LABU / Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
NKTR / Nektar Therapeutics
INCY / Incyte Corporation
RARE / Ultragenyx Pharmaceutical Inc.
IONS / Ionis Pharmaceuticals, Inc.
MTD / Mettler-Toledo International Inc.
IBB / iShares Trust - iShares Biotechnology ETF Put
VRTX / Vertex Pharmaceuticals Incorporated
CRL / Charles River Laboratories International, Inc.
QGEN / Qiagen N.V.
REGN / Regeneron Pharmaceuticals, Inc.
LGND / Ligand Pharmaceuticals Incorporated
ICPT / Intercept Pharmaceuticals Inc
REPH / Societal CDMO Inc
BIIB / Biogen Inc.
IQV / IQVIA Holdings Inc.
BMRN / BioMarin Pharmaceutical Inc.
GRFS / Grifols, S.A. - Depositary Receipt (Common Stock)
CELG / Celgene Corp.
UTHR / United Therapeutics Corporation
GILD / Gilead Sciences, Inc. Call
TECH / Bio-Techne Corporation
SGEN / Seagen Inc
ALKS / Alkermes plc
IBB / iShares Trust - iShares Biotechnology ETF
NBIX / Neurocrine Biosciences, Inc.
ILMN / Illumina, Inc.
AXSM / Axsome Therapeutics, Inc.